In the media

pharmaforum

October:
For patients coming off clinical trials, the post-trial access (PTA) mechanism of providing continued access to investigational medicines can often be most effective, though still not standardised. Suzanne Aitken, our SVP of Managed Access, discussed the benefits of PTA programmes in the current clinical trial landscape. Read more here.

Pharma Boardroom

September:
Nihad Hasagic, our SVP of Clinigen’s Lifecycle Services unit, explored the importance of providing end-to-end solutions that span the lifecycle of a medicine. Dive into this interesting interview here.

Pharma in Focus

September:
Hardus van Vuuren, the new Managing Director ANZ at Link Healthcare, a Clinigen company, discussed his new role leading 67 across Australia and New Zealand. He spoke to Pharma in Focus about his plans for the new role, boosting innovation, market access support and regional expertise to follow the Clinigen lifecycle mission. Read more here.

European Pharmaceutical Manufacturer

September:
Drug shortages are, unfortunately, an inevitable reality of the pharmaceutical industry. Ensuring that you get ahead of the impact of drug shortages by being agile and having the right regulatory affairs counsel is critical to ensuring the effects are not passed on to patients.

Senior Director of Regulatory Affairs, Melanie-Rose Brown, explored this complex topic for the latest edition of the EPM Magazine. Read here.

International Clinical Trials

August:
Tom Rose, our SVP of Clinical Trial Sourcing explored the benefits of both centralised and local sourcing strategies in the latest issue of International Clinical Trials magazine. Sourcing supply locally can be more secure for our clients' supply chain, but it can be costly for niche medicines – read more in the magazine’s 2025 summer edition here.

International Clinical Trials, Summer 2025, pages 4-6. © Samedan Ltd

pharmaphorum podcast

August:
In a rapidly evolving pharmaceutical landscape, ensuring patients have access to critical medicines is more challenging than ever. Managed Access Programmes (MAPs) are a key part of the solution, but they come with significant complexities.

Suzanne Aitken, our SVP of Managed Access, recently joined the Pharmaphorum podcast to discuss the vital role of these programmes. She shared her insights on how Clinigen helps navigate the sizeable global variations in regulations, and the need for the industry to be more inventive.

Dive into the fascinating discussion here.

Re:solve Global Health

March:
Gene therapy is a rapidly growing industry, offering new hope for patients of the more than 7,000 known rare diseases. However, setting prices that boosts gene therapies but makes access equitable is a challenge that businesses and regulators are currently tackling.

Susanne Michel, our Vice President of Market Access, Health Technology and Evidence at Clinigen, discusses the difficulties with pricing at the time of the drug launch and what we need to confront going forward. Read the full piece here.

Healthcare Today

March:
Access to medicines is one of the most impactful global gender disparities. At Clinigen, we’re committed to making a more equitable future in access to medicines. Former CEO Jerome Charton discussed the importance of equity in medical access for Healthcare Today, available here.

Chemist+Druggist

February:
No one should have to miss out on receiving the medicine they need because they live in a geographically isolated location. That’s why, in places like Bhutan, we are finding ways every day to remove geographical and regulatory boundaries to reach patients.

Suzanne Aitken, SVP of Managed Access, tackled this case study to explain how global reach combined with regional expertise can solve these challenges. Read on here.

Rare Disease Review

January:
Following 2024’s World Orphan Drug Congress Europe, Nicky Wisener, SVP of Business Development for Unlicensed Medicines, contributed to the Rare Disease Review newsletter to talk about orphan drugs. While there are still many access issues that providers are facing due to strict regulation and long approval processes, the orphan drug landscape is becoming more efficient and overall moving in a positive direction. Check out Nicky’s piece here.

Clinical Trials Insights

December:
Tom Rose, SVP Clinical Trial Sourcing explores how the pharmaceutical cold chain can achieve a balance between profit, planet, and patient benefit. Read his latest insights here (page 28).

World Pharmaceutical Frontiers, Clinical Trials Insights, Vol.2 2024, pages 28-30. © Business Trade Media International Limited

Health Industry Leaders

November:
Kieron Lewis, Director Strategic Consulting at Clinigen discusses how ESG principles can drive sustainable and equitable access to rare disease treatments, particularly within the complex EU regulatory environment. Read the article here (page 8).

Health Industry Leaders, Issue 9 2024, pages 8-10. © Peloton Events

Drug Discovery World (DDW)

September:
In the latest edition of Drug Discovery World, Suzanne Aitken, SVP for Managed Access at Clinigen, discusses the untapped potential of unlicensed medicines in addressing unmet patient needs, and why it's imperative for regulators and industry to work together in bridging the gap between existing therapies and patient access. Read the article here (page 6). 

Copyright 2024 © Drugs Discovery World (DDW)

International Clinical Trials (ICT)

August:
Tom Rose, SVP of Clinical Trial Sourcing at Clinigen, shares his insights on the future of clinical trial supply in the latest issue of International Clinical Trials. Discover how the pandemic, sustainability, and artificial intelligence are shaping the industry. Read the article here.

International Clinical Trials, Summer 2024, pages 82-85. © Samedan Ltd

Clinical Trials Insights

August:
Global Sourcing comparators for clinical trials is a complex challenge fraught with risk. Clinigen’s SVP of Clinical Trial Sourcing, Tom Rose, shares insights on navigating these complexities in a recent article for Clinical Trials Insights. Read the article here.

World Pharmaceutical Frontiers, Clinical Trials Insights, Vol. 1 2024, pages 32-34. © Business Trade Media International Limited

Health Industry Leaders

June:
In a recent interview with Health Industry Leaders, Clinigen's Suzanne Aitken discusses how the company's Managed Access programmes are bridging the gap between patients and life-saving medications by navigating complex regulatory landscapes. Read the article here.

Health Industry Leaders, Issue 4 2024, pages 12-15. © Peloton Events

PharmaTimes Magazine

June:
Suzanne Aitken, SVP Managed Access at Clinigen, delves into the complexities surrounding unlicensed medicines with Pharma Times Magazine. Read the article here.

© PharmaTime Media Ltd

Pharmaceutical Market Europe

April:
Global Patient Engagement Lead, Dr Lorna Pender spoke to Pharmaceutical Market Europe about the treatment options available to patients with rare diseases and the barriers that are hindering access. Read the article here.

Clinical Trials Insights

January:
Biosample safety in clinical trial management: Effective handling, management and storage of biospecimens are essential to guarantee trial validity. Read the article about the key considerations to comply with the environmental conditions and timelines required by the study.

International Clinical Trials

December:
Efficient cold chain management for advanced therapy trials: Cutting-edge cell and gene therapies come with increasing complexities around cold-chain logistics. Learn how clinical trial supply chains can progress to meet these evolving challenges effectively.

(International Clinical Trials, November 2023, pages 40-43. © Samedan Ltd)

Clinical Trials Insights

July:
Why should pharmaceutical companies care about sustainability when running a clinical trial? Read below to learn why sustainability should be considered for clinical trial supply chains and how partnering with an environmentally-conscious clinical supply provider such as Clinigen can help shorten timelines and cut costs.

Clinical Trials Insights

December 2022:
Cell and gene therapies require specific frozen cold-chain and storage capabilities. Learn how to ensure the integrity of your product with the right cold-chain clinical supplies management methods.

International Clinical Trials (ICT)

November 2022:
Therapies and cold-chain requirements are increasingly complex. Here's how sponsors can ensure their clinical trial supply chains can keep up with industry trends.

International Clinical Trials, Autumn 2022, pages 40-42. © Samedan Ltd

Clinical Trials Insights

June 2022:
The increase in pressure on the supply chain can put a trial’s clinical supplies management at risk. Learn how to equip your study with a solid supply programme from the onset to mitigate the impact of external influences.

Clinical Trials Insights

December 2021:
Risk-based optimisation minimises drug waste and reduces costs, all while enhancing patient service levels and accelerating timelines. Learn how to optimise trial supplies and post-trial patient access.

Clinical Trials Insights

July 2021:
COVID-19 is adding to the complexity of clinical trials. Identifying and sourcing suitable comparator products can therefore be a challenge that requires an agile approach. Learn how to effectively source comparator drugs amid a pandemic.

Clinical Trials Insights

December 2020:
Clinical studies are becoming increasingly complex and these complexities are driving up the cost of traditional clinical supply chain services. Learn how to streamline clinical trial supplies and reduce costs through flexible approaches to clinical supply chain management.

International Clinical Trials (ICT)

November 2020:
We live in an era of personalisation and with patients taking more control of their own health and treatment options, the advantages and challenges of different clinical trial methods are magnified. Learn about how a Direct-to-Patient model can improve patient engagement from Sarah Halmrast, VP Global Project Management.

Clinical Trials Insights

July 2020:
Clinical trials face an unprecedented set of challenges in the time of COVID-19. Discover how our agile approach and the use of Direct-to-Patient can alleviate the pressure on trial sponsors and patients.

Transport Media

June 2020:
Logistics in Wallonia, Belgium: Market access, infrastructure, and highly qualified workforce. Learn more from David Fontaine, Global VP of Marketing and Sales about what makes Mont-Saint-Guibert, the location of our Belgian facility, the ideal site for clinical trial supplies.

International Clinical Trials (ICT)

February 2020:
With patient-centricity high on the agenda, Direct-to-Patient can benefit all stakeholders of clinical trials. Learn more about this convenient and effective method of managing clinical supplies from Brian Swites, SVP of Clinical Services, Clinigen Group.

Clinical Trials Insights

January 2020:
Study changes, time constraints and many other factors can affect the packaging and labelling of products, putting a clinical trial at risk. Read about how On-Demand packaging and labelling can reduce waste.

Pharma Tech Outlook

December 2019:
Pharma Tech Outlook recognised us as Top 10 Clinical Trial Management Consulting/Services Companies in Europe 2019. Learn more about our comprehensive supply chain management solutions from Rüdiger Weber, SVP/General Manager EU.

Clinical Trials Insights

July 2019:
Changing regulations, importation requirements and many other factors can have a negative impact on international trials. Read the article on how to choose the right global clinical supplies partner.

Manufacturing Chemist

January 2019:
Although the packaging may not be the first factor to be considered when developing new medicines, it can cause great disruption if not handled properly. Read the article in the Manufacturing Chemist on the challenges when packaging for clinical trials.

Pharma Tech Outlook

December 2018:
Pharma Tech Outlook recognised us as Top 10 Supply Chain Solution Provider 2018. Learn more about our cost-effective and reliable supply chain management solutions.

GEN Magazine

November 2018:
Clinical Supplies Management featured in GEN Magazine – Michael Duda, Vice President of U.S. Biomedical Management Services and David Fontaine, Vice President of Global Marketing and Sales talk about our innovative strategies and unique solutions that ensure sample safety.

Clinical Trials Arena

November 2018:
Approaching Clinical Trials Where the Air Hurts Your Face: Colin Enz, Validation Manager & Russell Brierley from Lupin Research Inc talk about the key challenges involved in handling cryogenic products and how to address them.

Clinical Trials Insights

July 2018:
With the fast-growing industry, along with increased challenges, innovation is key to success. Read about the innovative On-Demand method which can drastically reduce cost and timelines.

Clinical Trials Insights

January 2018:
Read about the challenges clinical trials are facing due to BREXIT and solutions provided by the Clinical Supplies Management team to overcome them.